Human norovirus (hNoV) remains refractory to propagation in cell culture systems. We believe that knowing the exact cell type that hNoV targets will provide important insights into culturing the virus. By the use of an in vitro whole-virus binding assay, the hNoV genogroup II genotype 4 Sakai variant was found to bind predominantly to cells of the lamina propria and Brunner's glands, but not to those of the luminal epithelial surface, of human duodenum tissue. Our findings, together with accumulating evidence reported elsewhere, suggest that hNoV may display tropism to nonepithelial cells, which is distinct from observations of other human enteric pathogens.
Human norovirus (hNoV) is the leading cause of acute nonbacterial gastroenteritis worldwide and affects all age groups in both developed and developing countries (reviewed in references 1 and 9). In the past decades, research on the development of a robust in vitro culture system for hNoV has made little progress. The failure of attempts to culture the virus has severely hampered the study of the pathogenesis of this clinically important enteric pathogen and the development of antiviral therapy. Previous attempts to cultivate hNoV by the use of a broad panel of cell lines, including those resembling intestinal epithelium cells, were unsuccessful (8) . Recently, murine norovirus has been shown to propagate in mouse macrophage-like cell lines (e.g., RAW 264.7) and primary macrophages and dendritic cells (21) . Disappointingly, efforts to propagate hNoV in similar cell types derived from human peripheral blood mononuclear cells have remained futile (10) . Beyond the conventional in vitro culture model, one study reported that cells of a differentiated human embryonic small-intestinal cell line (INT 407), when grown as a threedimensional culture, supported hNoV infection and viral genome replication (18) . However, successful reproduction of the findings has not yet been reported. More encouraging findings have come from large-animal models. In studies of experimentally infected gnotobiotic pigs (5) and calves (17) , episodes of gastrointestinal symptoms resembling those of human acute gastroenteritis were occasionally observed. This suggests that other animal species may be susceptible to hNoV infection. The human relevance of these large-animal models for hNoV basic and clinical research deserves further investigations.
We believe knowing the exact cell type that hNoV targets would provide important insights into the future direction of hNoV cultivation efforts. In this report, using an in vitro wholevirus binding assay, we provide evidence demonstrating that the hNoV genogroup II genotype 4 (GII.4) Sakai variant bound predominantly to cells of the lamina propria and Brunner's glands, but not to cells of the luminal epithelial surface, of human duodenum tissue. Our findings suggest that hNoV may display tropism to nonepithelial cells, a finding distinct from observations of other human enteric pathogens. First, we selected one recent epidemic hNoV GII.4 Sakai variant collected locally in our earlier work (4). This hNoV GII.4 variant has been linked to outbreaks in health care facilities in different parts of Asia (13) . The virus was obtained from a stool specimen of a patient with a case of naturally occurring diarrhea with laboratory-confirmed hNoV GII.4 infection. The stool specimen gave negative test results by PCRs for human sapovirus and group A rotavirus (4) . A virus inoculum was prepared by making a 10% stool suspension in 1ϫ phosphate-buffered saline, followed by centrifugation at 3,000 ϫ g for 20 min. Supernatant was filtered through a 0.22-m-pore-size filter once, inactivated in 0.2% formalin for 8 h, and dialyzed against 1ϫ phosphate-buffered saline overnight before storage at Ϫ80°C until use. A quantitative realtime PCR assay (4) and a commercial immunoassay showed high levels of noroviral RNA (Fig. 1A) and protein (Fig. 1B,  left) , respectively, in the final stool filtrate. Further, immunoblot analysis revealed the presence of the 58-kDa noroviral major capsid protein (Fig. 1B, right) . Two stool filtrate controls, both of which tested negative for hNoV and one positive for and the other negative for group A rotavirus, were prepared and tested in parallel.
Next, we performed an in vitro whole-virus binding assay on archived formalin-fixed, paraffin-embedded human adult duodenal tissues. This assay has been widely used to study the differential tissue tropism characteristics of avian and human influenza viruses along the human respiratory tract (15, 20) . The duodenal region was selected based on clinical manifestations of a duodenojejunal mucosal lesion in hNoV-associated gastroenteritis (14) . Sections 5 m in thickness were prepared from tissue blocks and then deparaffinized in xylene, followed by rehydration in sequential ethanol gradients (from 100% down to 70%). Antigen retrieval was performed by boiling sections in 10 mM citrate buffer for 15 min. After cooling, sections were incubated with Dual Endogenous Enzyme Block (Dako) for 30 min, followed by Protein Block (Dako) for another 30 min. Sections were then incubated with the formalin-inactivated, virus-containing stool filtrate (1.5 ϫ 10 6 noroviral RNA copies [equivalent to 1.8 l of dialyzed stool filtrate in 25 l of Protein Block]) at 4°C overnight. After washing, sections were reblocked again, followed by incubation with monoclonal antibody against norovirus capsid protein (clone P7G3; Abcam) (10 g/ml) for 30 min. Color development was performed using an EnVisionϩ Dual Link kit (Dako) with diaminobenzidine as the enzyme substrate. Sections were counterstained with Gill's hematoxylin. We included several negative controls to validate the specificity of the staining: (i) isotype-matched immunoglobulin instead of the virus-specific antibody; (ii) stool filtrates that tested negative for hNoV and either positive or negative for group A rotavirus instead of the hNoV-containing stool filtrate; and (iii) antibody blocking of binding to tissues, in which hNoV stool filtrates were preincubated with different dilutions of NS14, an hNoV GII crossreactive monoclonal antibody, for 2 h prior to binding to sections. To confirm the identity of Brunner's glands, periodic acid-Schiff (PAS) staining and immunoperoxidase staining using mucin 6 (clone CLH5; Abcam) (10 g/ml), a monoclonal antibody against the Brunner's glands marker, were performed on sections without virus addition. Neighboring sections were used where applicable. Sections were washed with phosphatebuffered saline supplemented with Tween 20 between steps, where appropriate. All steps were performed at room temperature unless otherwise specified. The assay was performed on sections of 3 individuals. Our findings are summarized in Table 1 and Fig. 2 . All tissue donors examined were ethnic Chinese individuals; the donors included both strong and weak secretors, as determined by saliva phenotyping and genotyping assays (see Methods in the supplemental materials). In the human duodenum samples, the hNoV GII.4 Sakai variant attached predominantly to cells of the lamina propria independently of donors' secretor status ( Fig. 2C and Table 1 ). The specificity of the staining was verified by the absence of signal in the isotype-matched immunoglobulin control (Fig. 2E ) and both stool filtrate controls ( Fig. 2G and I ). In addition, antibody blocking abolished in vitro whole-virus binding in a dose-dependent manner (Fig. 3) . Our findings agree with the limited experimental hNoV infection data from studies of humans (10) and chimpanzees (2), which describe viral capsid protein expression in cells of the small-intestinal lamina propria. However, they are in contrast to data from nonprimate pig and calf models of hNoV infection indicating that the viral capsid antigen was commonly detected in villous enterocytes and was virtually absent from the lamina propria along animal small intestines (5, 17) . Inter-
FIG. 1. Characterization of formalin-inactivated stool filtrates used in in vitro whole-virus binding assays. A quantitative real-time PCR
assay and an enzyme-linked immunosorbent assay (ELISA) showed high levels of norovirus RNA (A) and protein (B, left), respectively, in the virus-containing stool filtrate but not in the other 2 stool filtrate controls. Immunoblotting revealed the presence of the 58-kDa noroviral major capsid protein (B, right). Quantitative PCR targeting the polymerase/capsid gene junction was performed as we previously described (4). Viral antigen detection (with an input stool filtrate volume of 1.8 l) was performed using an ELISA-based Ridascreen Norovirus 3rd generation kit (r-biopharm) per the manufacturer's instructions. The major viral capsid protein (58 kDa) was detected using the same antibody cocktail as was used in the ELISA. A total of 7 g of protein was loaded per lane in the immunoblot. estingly, whereas positive PAS staining of brush borders showed that the epithelial lining of the sections was intact ( Fig.  2A) , we observed no virus binding to luminal and crypt epithelial surfaces. This disagrees with an earlier in vitro binding study by Marionneau et al. performed using virus-like particles (VLPs) of Norwalk virus (NV; hNoV GI.1), the prototype of hNoV (12) . In their study, baculovirus-expressed recombinant NV VLPs were found to bind exclusively to gastroduodenal epithelial cells. This discrepancy may be attributable to the nature of the stool filtrate or the virus strain used. It has long been recognized that hNoVs exhibit diverse patterns of binding to histo-blood group antigens (HBGAs) (7, 11, 16) . However, staining using lectin isolated from Ulex europaeus showed that cells of the lamina propria to which the Sakai variant attached did not express histo-blood group H antigen (Fig. 2M) . This is not surprising, given recent findings that, unlike NV VLPs, Sakai variant VLPs exhibit virtually no binding to HBGAs (11) , although conflicting binding data exist from studies when P-domain protein was used instead of VLPs (22) . Other host surface molecules may be involved in the whole-virus binding, as proposed by others (3). In addition to the binding to cells of the lamina propria, we also observed that the virus attached to submucosal structures resembling Brunner's glands (Fig. 2D) . The identity of Brunner's glands was confirmed by coexpression of the cell marker mucin 6 on neighboring sections (Fig.  2L) . The specificity of the staining was supported by the absence or abolishment of signal in all negative controls (Fig. 2F , H, and J and Fig. 3) . Accumulating evidence has hinted that hNoV might target intestinal nonepithelial cells instead of enterocytes. First, direct data showing that hNoV infects enterocytes are still lacking. Second, early work from volunteers challenged with Ha- waii agent (hNoV GII.1) indeed failed to detect virus particles in small-intestinal epithelial cells by the use of electron microscopy even when gastroenteritis symptoms and histopathological changes, such as blunted villi and shortened microvilli, were observed in the infected individuals (6) . Third, the latest evidence from a chimpanzee model of hNoV infection indicates that the virus displays tissue tropism to cells of the smallintestinal lamina propria (2) . Collectively, the general belief that hNoV targets the intestinal epithelium, as in other enteric viruses such as rotavirus, may need to be revisited, and our findings support this thought. If it is true that hNoV targets nonepithelial cells, an immediate important issue is that of determining how the virus penetrates the intact intestinal epithelial lining. Our observation that hNoV also attached to Brunner's glands may provide some hints. Submucosal Brunner's glands, found primarily in the proximal duodenum between the pyloroduodenal junction and the entrance of the pancreatic duct, are open to crypts and intestinal lumen through an extensive network of ducts (19) . We speculate that the virus may explore luminal openings of submucosal glands as the portal of entry into the lamina propria of the human small intestine. Our study has limitations. We examined only virus binding to human duodenal tissues. Further investigation using other parts of the small intestine-the jejunum and the ileum-is needed. Moreover, considering that the HBGA binding patterns of hNoV differ between virus genogroups, genotypes, and even strains, the question of whether other hNoVs (non-Sakai) share similar tissue tropism characteristics remains to be answered.
In summary, we provide evidence that the hNoV GII.4 Sakai variant recognizes cells of the lamina propria and Brunner's glands, but not those of the luminal epithelial surface, of human duodenum tissue in vitro. hNoV may display tropism to nonepithelial cells, with implications for the future direction of hNoV cultivation efforts.
